Company Filing History:
Years Active: 2017
Title: Denis George Kay: Innovator in Neurodegenerative Disease Research
Introduction
Denis George Kay is a notable inventor based in Stratford, CA. He has made significant contributions to the field of neurodegenerative disease research through his innovative work. His expertise and dedication have led to the development of valuable patents that aim to improve understanding and treatment of these complex conditions.
Latest Patents
Denis George Kay holds a patent for "Nurotoxic sterol glycosides." This invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, it involves the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof, in animal models of neurodegenerative disease. Additionally, neurotoxicity-modulating chromenols can also be utilized in these animal models in combination with the neurotoxic sterol glycosides or neurotoxic glycolipids.
Career Highlights
Throughout his career, Denis has focused on advancing the understanding of neurodegenerative diseases. His work has been instrumental in developing new methodologies that can potentially lead to breakthroughs in treatment options. With a patent count of 1 patent, his contributions are recognized within the scientific community.
Collaborations
Denis collaborates with Christopher Ariel Shaw, working together to further their research and innovations in the field of neurodegenerative diseases. Their partnership exemplifies the importance of teamwork in scientific advancements.
Conclusion
Denis George Kay's innovative work in neurodegenerative disease research highlights the critical role of inventors in advancing medical science. His contributions through patents and collaborations continue to pave the way for future discoveries in this vital area of health.